Biocompatibility is one of the most important characteristics of a biomedical polymer material
whose surface is required to interact with a biological system. Such interactions between …

Focusing on a lucrative and increasingly important area of biomedicine, the Biomaterials
Fabrication and Processing Handbook brings together various biomaterials production and …

Covalent antithrombin–heparin complex (ATH) was covalently grafted to a polycarbonate
urethane (Corethane®) endoluminal graft (a kind gift of Corvita Corporation) after being …

The third edition of a bestseller, this substantially expanded reference, now in two volumes,
presents the latest polymer developments and most up-to-date applications of polymeric …

Unfractionated heparin (UFH) and low molecular weight heparin (LMWH) have been utilized
as primary anticoagulants for thrombosis prophylaxis and treatment. However, a number of …

Unfractionated heparin (UFH) and low molecular weight heparin (LMWH) are used for
prophylaxis and treatment of thrombosis. However, UFH has a short plasma half-life and …

Catheter use has been associated with an incresed risk of thrombotic complications. The
objective was to make catheters less thrombogenic with the use of antithrombin-heparin …

The clinical limitations of unfractionated heparin (UFH) and low molecular weight heparin
(LMWH) led to the development of an antithrombin–heparin covalent complex (ATH), which …

Numerous studies have shown that fibrin-bound thrombin (IIa) is proteched from inhibition
by antithrombin (AT)+ heparin (II) due to the formation if R ternary fibrin. IIa. H complex of AT …

We have developed an antithrombin-heparin covalent complex (ATH) which inhibits
coagulation enzymes by two mechanisms: directly, or by catalytic activation of plasma …